| Q40754780 | Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage |
| Q69959585 | Cerebellar injury due to phenytoin. Identification and evolution of Purkinje cell axonal swellings in deep cerebellar nuclei of mice |
| Q41647777 | Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves |
| Q68235514 | Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat |
| Q34800367 | Neurofilaments in diabetic neuropathy |
| Q34800404 | Neuropathology and pathogenesis of diabetic autonomic neuropathy |
| Q40932253 | Pathology and pathogenetic mechanisms of diabetic neuropathy. |
| Q90198443 | Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea |
| Q72616658 | The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat |
| Q34087403 | Ultrastructural changes in the hypothalamic supraoptic nucleus of the streptozotocin-induced diabetic rat. |